Live news related to INNATE PHARMA stock (FR0010331421): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on INNATE PHARMA mainly cover M&A activity, analyst notes et guidance and outlook. The stock trades at €1,26 on Euronext Paris, down 2,18% at the last update. This page lists the articles published on INNATE PHARMA stock to track the share price, company announcements and any item likely to influence market perception.
In a press release published on October 27, 2026, Innate Pharma announced that AstraZeneca, which is conducting the trial, has updated the planned tim…
In a press release published on October 21, 2026, the Marseille-based biotech announced that members of its management team will engage with the finan…
Innate Pharma published its first half 2026 results on September 17, 2026, dominated by the finalization of its partnership with Sobi around lacutamab…
The fulfillment of closing conditions, including the expiration of regulatory review periods by competition authorities, activates the licensing agree…
The Marseille-based biotechnology group announced its participation in a leading virtual conference organized by BTIG on July 28, 2026. Sonia Quaratin…
The biopharmaceutical laboratory announced the completion of recruitment in the dose escalation part of its Phase 1 study evaluating IPH4502, a drug-c…
Portzamparc ajuste ce vendredi son objectif de cours sur Innate Pharma.
